KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares Repurchased
Ratios

Fulgent Genetics (FLGT) Other Gross PP&E Adjustments (2016 - 2025)

Fulgent Genetics (FLGT) has disclosed Other Gross PP&E Adjustments for 11 consecutive years, with $150.6 million as the latest value for Q4 2025.

  • Quarterly Other Gross PP&E Adjustments rose 0.52% to $150.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $150.6 million through Dec 2025, up 0.52% year-over-year, with the annual reading at $150.6 million for FY2025, 0.52% up from the prior year.
  • Other Gross PP&E Adjustments hit $150.6 million in Q4 2025 for Fulgent Genetics, down from $159.1 million in the prior quarter.
  • In the past five years, Other Gross PP&E Adjustments ranged from a high of $160.2 million in Q2 2025 to a low of $58.9 million in Q1 2021.
  • Historically, Other Gross PP&E Adjustments has averaged $114.3 million across 5 years, with a median of $117.2 million in 2023.
  • Biggest five-year swings in Other Gross PP&E Adjustments: surged 413.52% in 2021 and later decreased 0.46% in 2024.
  • Year by year, Other Gross PP&E Adjustments stood at $73.0 million in 2021, then surged by 46.91% to $107.3 million in 2022, then increased by 9.26% to $117.2 million in 2023, then grew by 27.82% to $149.8 million in 2024, then increased by 0.52% to $150.6 million in 2025.
  • Business Quant data shows Other Gross PP&E Adjustments for FLGT at $150.6 million in Q4 2025, $159.1 million in Q3 2025, and $160.2 million in Q2 2025.